Displaying results 1 - 25 of 116 for genetic. Subscribe to this search
LOS ANGELES--(BUSINESS WIRE)--Dec 12, 2013--For those who have battled cancer, each tomorrow is, in reality, a dream come true. No one knows that better than the 11 cancer survivors who will ride City of Hope’s float at the 125 th Rose Parade on New Year’s Day.
Sarasota county leaders will name a 287 acre property next to Oscar Scherer state park the Scherer Thaxton preserve.
NEW YORK (AP) — The U.S. stock market has opened slightly lower after another day of record highs. The breather comes as international stock markets were flat or edging lower as well Tuesday. The Dow Jones industrial average slipped 18 points to 16,007. The Standard & Poor's 500 index was down three points to 1,805, just below its all-time closing high Monday. The Nasdaq composite fell six points to 4,062.
IRVINE, Calif.--(BUSINESS WIRE)--Dec 10, 2013--Apira Science, Inc. has named China Central Pharmaceuticals Ltd. its exclusive distributor of the iGrow ® Hair Growth System in the Chinese market. The partnership highlights Apira’s growing success in the global market, and showcases the burgeoning international demand for a safe and effective hair loss solution. China Central Pharmaceuticals is a 10 billion yuan ($1.6 billion) corporation that houses 28 pharmaceutical subsidiaries and sells more than 20,000 medical products, including 6,000 new drugs, 1,000 medical devices, and 1,800 foreign products throughout China. Through the partnership, the iGrow will be featured in more than 6,000 retail outlets in addition to hospitals and medical facilities throughout China. Within the 33.6 billion yuan ($5.5 billion) Chinese hair care market, sales of Western hair-loss treatments grew 90 percent from 2007 to 2012. Because of its size and marketing effectiveness, China Central represents one of the largest global distribution opportunities to date in Apira Science’s extensive roster of iGrow Hair Growth System sales networks worldwide.
NEW ORLEANS--(BUSINESS WIRE)--Dec 9, 2013--Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced updated overall survival data from two ADCETRIS (brentuximab vedotin) pivotal Phase 2 clinical trials in relapsed/refractory Hodgkin lymphoma (R/R HL) and relapsed/refractory systemic anaplastic large cell lymphoma (R/R sALCL) were presented at the 55 th American Society of Hematology (ASH) Annual Meeting and Exposition taking place in New Orleans, LA, December 7-10, 2013. ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30. Median overall survival (OS) of 40.5 months was reported in R/R HL, and was not yet reached in R/R sALCL.
CHESHIRE, Conn.--(BUSINESS WIRE)--Dec 8, 2013--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that researchers presented data from clinical trials demonstrating the clinical benefits of chronic Soliris ® (eculizumab) treatment in patients with atypical hemolytic uremic syndrome (aHUS) as well as new patient registry data providing further insight into optimal care for patients with paroxysmal nocturnal hemoglobinuria (PNH) at the American Society of Hematology (ASH) 55th Annual Meeting and Exposition in New Orleans. Data included:
NEW YORK (AP) — Stocks are up sharply in early trading on Wall Street after the U.S. government reported a big increase in hiring last month. The gains are extraordinarily broad, with 98 percent of the stocks in the S&P 500 index rising. It's the first increase for the market this week.
MOUNTAIN VIEW, Calif. (AP) — Genetic testing company 23andMe says it is complying with a Food and Drug Administration directive to stop selling health-related genetic tests during a regulatory review.
(NAPSI)—Nationwide, more than 12 million people have been diagnosed with chronic obstructive pulmonary disease (COPD), and it is estimated that as many as 12 million more have the symptoms but are unaware that they have the disease. There is no cure for COPD, and if left untreated, it can affect everyday life, making it harder for people to do the things they enjoy. With early diagnosis and proper treatment, however, COPD can be managed, enabling people to stay active and feel better.
CAMBRIDGE, Mass. & STOCKHOLM--(BUSINESS WIRE)--Dec 4, 2013--Today Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) announced the publication of detailed results from the pivotal Phase 3 study of ALPROLIX TM, the companies’ investigational long-lasting recombinant factor IX Fc fusion protein candidate for hemophilia B. The study appears in the Online First edition and will appear in the December 12 print issue of The New England Journal of Medicine (NEJM).
NEW YORK (AP) — Stocks are now on a three-session losing streak. The Dow lost 94 points to 15,914 today, while the S&P 500 fell nearly six points to 1,795, and the Nasdaq fell 8 to 4,037. Shares of Ford and General Motors fell around 3 percent despite generally good sales reports for November.
WASHINGTON (AP) — Genetic testing company 23andMe is facing a class action lawsuit alleging that the Silicon Valley startup misled customers about its test kit.
Women with a family history of BRCA2 mutations who test negative for the family-specific BRCA2 mutations are still at greater risk for developing breast cancer compared with women in the general population, according to a recent study.
BAKERSVILLE, N.C. (AP) — There's something rotten in Christmas tree country. And that has some farmers looking overseas for a solution.
DENVER, Co. (Ivanhoe Newswire) --Once called juvenile diabetes, type 1 diabetes is a serious illness requiring a lifetime of injections. 215,000 kids and adults are currently living with this type of diabetes. New research reveals what you feed your baby could play a significant role in the chances of your little one developing the disease.
There are only a few "cooking turkey" tips that are elemental.
(NAPSI)—In 2008, chronic obstructive pulmonary disease (COPD) surpassed stroke to become the third-leading cause of death in the United States. Nationwide, more than 12 million Americans have been diagnosed with COPD while millions more are unaware they may have the disease. Yet, for the serious burden COPD poses on American public health and people’s quality of life, detailed nationwide data on who is most affected by this disease has been scarce.
FLORENCE, Italy (AP) — The prosecutor arguing U.S. student Amanda Knox's guilt in the 2007 murder of her British roommate says a DNA sample on the blade of the presumed murder weapon was clean and corresponds to the victim.
NEW YORK (AP) — The stock market has ended the day's trading relatively flat. The Dow rose eight points to close at 16,073, while the S&P 500 eased back two points to 1,802. The Nasdaq rose three points to 3,995. News of a deal to curtail Iran's nuclear ambitions had traders anticipating more supply and lower oil prices, making the energy sector the biggest decliner in the S&P 500.
WASHINGTON (AP) — The Food and Drug Administration is ordering genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is backed by science.
(NAPSI)—A house full of guests. Cooking for a crowd. Financial pressures and end-of-year deadlines. For many, the holidays can evoke feelings of stress rather than cheer. For people living with chronic rare diseases like Michelle Hardy, stress may have an even greater impact.